Home Briefs Stories
More
Explore Browse Topics
← Stories Briefs
Story 1 source • Updated 3 days ago • top: bloomberg.com

Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million

This is a live story built from multiple sources. It may evolve quickly.
Coverage meter • 17 hr window
Back to home Open top source
B bloomberg.com
What’s included
Top recent items from this story.
2 items • 2 unique links
Bloomberg Markets 3 days ago • bloomberg.com
Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO
Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering.
Open
Bloomberg Markets 4 days ago • bloomberg.com
Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million
Kailera Therapeutics Inc., a clinical-stage biotechnology company focused on obesity, raised $625 million in an upsized initial public offering, marking the sector’s biggest US listing since 2021.
Open